Advertisement

Topics

Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1

03:27 EDT 2 Aug 2017 | Nature Publishing

Original Article: Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1

NEXT ARTICLE

More From BioPortfolio on "Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1"

Quick Search
Advertisement